about
Colony stimulating factor 3 (granulocyte)Sp3 transcription factorZinc finger protein, FOG family member 1Spi-1 proto-oncogeneL3MBTL histone methyl-lysine binding protein 3CCAAT enhancer binding protein alphaCCAAT enhancer binding protein epsilonCBFA2/RUNX1 partner transcriptional co-repressor 3NFKB activating proteinZinc finger protein, multitype 1CCAAT/enhancer binding protein (C/EBP), alphaCCAAT/enhancer binding protein (C/EBP), epsilonCbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2Spleen focus forming virus (SFFV) proviral integration oncogeneCBFA2/RUNX1 translocation partner 3Lysine (K)-specific demethylase 1ANFKB activating proteinL3MBTL3 histone methyl-lysine binding proteinTrans-acting transcription factor 3CCAAT/enhancer binding protein epsilonSpi-1 proto-oncogeneCCAAT/enhancer binding protein alphaCbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2L3MBTL histone methyl-lysine binding protein 3Colony stimulating factor 3CCAAT enhancer binding protein epsilon
P682
AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiationNeutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilonMutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.
P921
Q14863144-9CC86F2E-8E45-4F9E-9175-39B4701C8D4DQ21107297-CE04D2D2-2867-4886-9177-300D027FF750Q21107363-ED04FD43-957C-4072-9D8B-904CC4FAFE5AQ21108730-52AC736C-541A-44DD-9146-8DAF55129826Q21116276-DD98BB9B-E4F8-421C-AB71-9F9C624DE902Q21116819-781C15FD-0167-4B6F-957F-45A8D4673A8EQ21117188-B203A639-6737-40C7-8627-A53EC2F992D5Q21120058-AC2D6B9C-F89B-4EE2-8919-7E929DBC0114Q21172301-139B98C8-3335-4D51-AAF8-D6C54E542C17Q21498462-AA0E76A7-6844-48B7-AF65-543D79850494Q21499243-B8431A64-C0F4-4394-BF89-30E5E2733D2BQ21499248-D46D648C-00EC-4D2E-9A20-86DD17BD2AE5Q21499275-49D47E32-86D9-4ADA-AFA2-584FA6438DB3Q21981396-0739678B-39F8-44D7-97B3-BCA6F83B28ECQ21985069-0D4DC651-4A9F-48CA-9622-EA6AC92AD49DQ21985069-C84DF963-3DA7-4AA2-A535-C4B7E78410AFQ21987128-7AC024FC-9059-4469-8F08-FCD47E9CCEE6Q21987311-12B22460-6BC9-4B70-AEA5-0A79E57A38C7Q21989308-FFDE2372-D885-4DD2-9F59-678C524C572FQ21991170-524D2BA2-F70C-4CBA-91A7-2EF1D5F9A228Q28559852-C5E9C751-ECF7-4650-9E5A-CCFCC80729C4Q28560741-0BA8D16A-9DCA-4B1B-88AC-E853FA6DE30CQ28563178-F2599305-27BA-483F-8A66-0E613C524751Q29519419-2D04D160-34F3-40C4-BD18-8A4F638C87B2Q29526030-319F44CC-028B-4A08-A179-95E775777062Q419327-74060121-CB97-45B4-9339-320963DF1B08Q55202647-F08CDFB7-291A-42BF-B7FC-360B97747035
P682
description
The process in which a myeloid ...... e in allergic immune reactions
@en
biologisch proces
@nl
name
granulocyte differentiation
@en
type
label
granulocyte differentiation
@en
altLabel
GO:0030851
@en
granulocyte cell differentiation
@en
prefLabel
granulocyte differentiation
@en
P2888
P686
GO:0030851